EKS-HOS-00289
Eukaryotic Protein Kinase & Protein Phosphatase Database
TagContent
EKPD IDEKS-HOS-00289
Classification
Group/FamilyScoreE-ValueStartEndDomain Length
TKL/STKR408.57.4E-122190477288
StatusReviewed
Ensembl ProteinENSP00000340361
UniProt AccessionQ13705; Q4VAV0;
Protein NameActivin receptor type-2B
Protein Synonyms/Alias Activin receptor type IIB; ACTR-IIB;
Gene NameACVR2B
Gene Synonyms/Alias ACVR2B;
Ensembl Information
Ensembl Gene IDEnsembl Protein IDEnsembl Transcript ID
ENSG00000114739ENSP00000340361ENST00000352511
OrganismHomo sapiens
Functional DescriptionTransmembrane serine/threonine kinase activin type-2receptor forming an activin receptor complex with activin type-1 serine/threonine kinase receptors (ACVR1, ACVR1B or ACVR1c). Transduces the activin signal from the cell surface to the cytoplasm and is thus regulating many physiological and pathological processes including neuronal differentiation and neuronal survival, hair follicle development and cycling, FSH production by the pituitary gland, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. Activin is also thought to have a paracrine or autocrine role in follicular development in the ovary. Within the receptor complex, the type-2 receptors act as a primary activin receptors (binds activin-A/INHBA, activin-B/INHBB as well as inhibin-A/INHA-INHBA). The type-1 receptors like ACVR1B act as downstream transducers of activin signals. Activin binds to type-2 receptor at the plasma membrane and activates its serine-threonine kinase. The activated receptor type-2 then phosphorylates and activates the type-1 receptor. Once activated, the type-1 receptor binds and phosphorylates the SMAD proteins SMAD2 and SMAD3, on serine residues of the C-terminal tail. Soon after their association with the activin receptor and subsequent phosphorylation, SMAD2 and SMAD3 are released into the cytoplasm where they interact with the common partner SMAD4. This SMAD complex translocates into the nucleus where it mediates activin-induced transcription. Inhibitory SMAD7, which is recruited to ACVR1B through FKBP1A, can prevent the association of SMAD2 and SMAD3 with the activin receptor complex, thereby blocking the activin signal. Activin signal transduction is also antagonized by the binding to the receptor of inhibin-B via the IGSF1 inhibin coreceptor.
Protein Length512
Protein Sequence
(FASTA)
MTAPWVALAL LWGSLCAGSG RGEAETRECI YYNANWELER TNQSGLERCE GEQDKRLHCY 60
ASWRNSSGTI ELVKKGCWLD DFNCYDRQEC VATEENPQVY FCCCEGNFCN ERFTHLPEAG 120
GPEVTYEPPP TAPTLLTVLA YSLLPIGGLS LIVLLAFWMY RHRKPPYGHV DIHEDPGPPP 180
PSPLVGLKPL QLLEIKARGR FGCVWKAQLM NDFVAVKIFP LQDKQSWQSE REIFSTPGMK 240
HENLLQFIAA EKRGSNLEVE LWLITAFHDK GSLTDYLKGN IITWNELCHV AETMSRGLSY 300
LHEDVPWCRG EGHKPSIAHR DFKSKNVLLK SDLTAVLADF GLAVRFEPGK PPGDTHGQVG 360
TRRYMAPEVL EGAINFQRDA FLRIDMYAMG LVLWELVSRC KAADGPVDEY MLPFEEEIGQ 420
HPSLEELQEV VVHKKMRPTI KDHWLKHPGL AQLCVTIEEC WDHDAEARLS AGCVEERVSL 480
IRRSVNGTTS DCLVSLVTSV TNVDLPPKES SI 512
Nucleotide Sequence
(FASTA)
ATGACGGCGC CCTGGGTGGC CCTCGCCCTC CTCTGGGGAT CGCTGTGCGC CGGCTCTGGG 60
CGTGGGGAGG CTGAGACACG GGAGTGCATC TACTACAACG CCAACTGGGA GCTGGAGCGC 120
ACCAACCAGA GCGGCCTGGA GCGCTGCGAA GGCGAGCAGG ACAAGCGGCT GCACTGCTAC 180
GCCTCCTGGC GCAACAGCTC TGGCACCATC GAGCTCGTGA AGAAGGGCTG CTGGCTAGAT 240
GACTTCAACT GCTACGATAG GCAGGAGTGT GTGGCCACTG AGGAGAACCC CCAGGTGTAC 300
TTCTGCTGCT GTGAAGGCAA CTTCTGCAAC GAACGCTTCA CTCATTTGCC AGAGGCTGGG 360
GGCCCGGAAG TCACGTACGA GCCACCCCCG ACAGCCCCCA CCCTGCTCAC GGTGCTGGCC 420
TACTCACTGC TGCCCATCGG GGGCCTTTCC CTCATCGTCC TGCTGGCCTT TTGGATGTAC 480
CGGCATCGCA AGCCCCCCTA CGGTCATGTG GACATCCATG AGGACCCTGG GCCTCCACCA 540
CCATCCCCTC TGGTGGGCCT GAAGCCACTG CAGCTGCTGG AGATCAAGGC TCGGGGGCGC 600
TTTGGCTGTG TCTGGAAGGC CCAGCTCATG AATGACTTTG TAGCTGTCAA GATCTTCCCA 660
CTCCAGGACA AGCAGTCGTG GCAGAGTGAA CGGGAGATCT TCAGCACACC TGGCATGAAG 720
CACGAGAACC TGCTACAGTT CATTGCTGCC GAGAAGCGAG GCTCCAACCT CGAAGTAGAG 780
CTGTGGCTCA TCACGGCCTT CCATGACAAG GGCTCCCTCA CGGATTACCT CAAGGGGAAC 840
ATCATCACAT GGAACGAACT GTGTCATGTA GCAGAGACGA TGTCACGAGG CCTCTCATAC 900
CTGCATGAGG ATGTGCCCTG GTGCCGTGGC GAGGGCCACA AGCCGTCTAT TGCCCACAGG 960
GACTTTAAAA GTAAGAATGT ATTGCTGAAG AGCGACCTCA CAGCCGTGCT GGCTGACTTT 1020
GGCTTGGCTG TTCGATTTGA GCCAGGGAAA CCTCCAGGGG ACACCCACGG ACAGGTAGGC 1080
ACGAGACGGT ACATGGCTCC TGAGGTGCTC GAGGGAGCCA TCAACTTCCA GAGAGATGCC 1140
TTCCTGCGCA TTGACATGTA TGCCATGGGG TTGGTGCTGT GGGAGCTTGT GTCTCGCTGC 1200
AAGGCTGCAG ACGGACCCGT GGATGAGTAC ATGCTGCCCT TTGAGGAAGA GATTGGCCAG 1260
CACCCTTCGT TGGAGGAGCT GCAGGAGGTG GTGGTGCACA AGAAGATGAG GCCCACCATT 1320
AAAGATCACT GGTTGAAACA CCCGGGCCTG GCCCAGCTTT GTGTGACCAT CGAGGAGTGC 1380
TGGGACCATG ATGCAGAGGC TCGCTTGTCC GCGGGCTGTG TGGAGGAGCG GGTGTCCCTG 1440
ATTCGGAGGT CGGTCAACGG CACTACCTCG GACTGTCTCG TTTCCCTGGT GACCTCTGTC 1500
ACCAATGTGG ACCTGCCCCC TAAAGAGTCA AGCATCTAA 1539
Domain Profile
S: 1     lklleligkGrygeVwkaklrgeevAvKifstedeaswkrEkeiyqtvllrhenilqfia  60
         l+lle+ ++Gr+g+Vwka+l+++ vAvKif+ +d++sw++E+ei++t+ ++hen+lqfia
Q: 190   LQLLEIKARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIA  249
         6899********************************************************
S: 61    adkkeedsltelllvteyhekgsLsdyLkretldveellrlalslasGlahLHeeivgtk  120
         a+k+ +++++el+l+t++h+kgsL+dyLk ++++++el+++a+++++Gl++LHe++++++
Q: 250   AEKRGSNLEVELWLITAFHDKGSLTDYLKGNIITWNELCHVAETMSRGLSYLHEDVPWCR  309
         ************************************************************
S: 121   g.kkKpaiaHRDlkskNilvkkdltcciaDlGLalkleeekeeldlaansqvGtkRYmaP  179
         g  +Kp+iaHRD+kskN+l+k+dlt+++aD+GLa+++e  k   d  ++ qvGt+RYmaP
Q: 310   GeGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGD--THGQVGTRRYMAP  367
         *99***************************************888..79***********
S: 180   EvleealnlkdfeafkraDvYslgLvlWEvasRceevdeeveeyklpfeevvgsdPslee  239
         Evle+a+n+++ +af r+D+Y++gLvlWE++sRc+++d+ v+ey+lpfee++g++Pslee
Q: 368   EVLEGAINFQR-DAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLEE  426
         **********9.9***********************************************
S: 240   mkevvvekklrPkipeawkkkealkelsklleecWdadpeaRltalrvkkr  290
         ++evvv+kk+rP+i+++w k++ l++l+ ++eecWd+d+eaRl+a +v++r
Q: 427   LQEVVVHKKMRPTIKDHWLKHPGLAQLCVTIEECWDHDAEARLSAGCVEER  477
         ************************************************998
Domain Sequence
(FASTA)
LQLLEIKARG RFGCVWKAQL MNDFVAVKIF PLQDKQSWQS EREIFSTPGM KHENLLQFIA 60
AEKRGSNLEV ELWLITAFHD KGSLTDYLKG NIITWNELCH VAETMSRGLS YLHEDVPWCR 120
GEGHKPSIAH RDFKSKNVLL KSDLTAVLAD FGLAVRFEPG KPPGDTHGQV GTRRYMAPEV 180
LEGAINFQRD AFLRIDMYAM GLVLWELVSR CKAADGPVDE YMLPFEEEIG QHPSLEELQE 240
VVVHKKMRPT IKDHWLKHPG LAQLCVTIEE CWDHDAEARL SAGCVEER 288
Keyword3D-structure; Alternative splicing; ATP-binding; Cell membrane; Complete proteome; Disease mutation; Disulfide bond; Glycoprotein; Heterotaxy; Kinase; Magnesium; Manganese; Membrane; Metal-binding; Nucleotide-binding; Phosphoprotein; Polymorphism; Receptor; Reference proteome; Serine/threonine-protein kinase; Signal; Transferase; Transmembrane; Transmembrane helix.
Sequence SourceEnsembl
Orthology
Ortholog group
Ailuropoda melanoleuca"; ?>Anolis carolinensis"; ?>Bos taurus"; ?>Caenorhabditis elegans"; ?>Callithrix jacchus"; ?>Canis familiaris"; ?>Cavia porcellus"; ?>Ciona intestinalis"; ?>Ciona savignyi"; ?>Danio rerio"; ?>Drosophila melanogaster"; ?>Equus caballus"; ?>Felis catus"; ?>Gadus morhua"; ?>Gallus gallus"; ?>Gasterosteus aculeatus"; ?>Gorilla gorilla"; ?>Ictidomys tridecemlineatus"; ?>Latimeria chalumnae"; ?>Loxodonta africana"; ?>Macaca mulatta"; ?>Meleagris gallopavo"; ?>Microcebus murinus"; ?>Monodelphis domestica"; ?>Mus musculus"; ?>Mustela putorius furo"; ?>Nomascus leucogenys"; ?>Oreochromis niloticus"; ?>Ornithorhynchus anatinus"; ?>Oryzias latipes"; ?>Otolemur garnettii"; ?>Pan troglodytes"; ?>Pelodiscus sinensis"; ?>Petromyzon marinus"; ?>Pongo abelii"; ?>Pteropus vampyrus"; ?>Rattus norvegicus"; ?>Sarcophilus harrisii"; ?>Sus scrofa"; ?>Taeniopygia guttata"; ?>Takifugu rubripes"; ?>Tetraodon nigroviridis"; ?>Tupaia belangeri"; ?>Tursiops truncatus"; ?>Xenopus tropicalis"; ?>Xiphophorus maculatus"; ?>
EKS-AIM-00265
EKS-ANC-00271
EKS-BOT-00283
EKS-CAE-00245
EKS-CAJ-00289
EKS-CAF-00289
EKS-CAP-00318
EKS-CII-00166
EKS-CIS-00047
EKS-DAR-00628
EKS-DRM-00144
EKS-EQC-00275
EKS-FEC-00269
EKS-GAM-00177
EKS-GAG-00236
EKS-GAA-00346
EKS-GOG-00282
EKS-ICT-00267
EKS-LAC-00294
EKS-LOA-00293
EKS-MAM-00285
EKS-MEG-00223
EKS-MIM-00021
EKS-MOD-00278
EKS-MUM-00314
EKS-MUP-00278
EKS-NOL-00261
EKS-ORN-00364
EKS-ORA-00249
EKS-ORL-00340
EKS-OTG-00288
EKS-PAT-00267
EKS-PES-00252
EKS-PEM-00152
EKS-POA-00274
EKS-PTV-00040
EKS-RAN-00299
EKS-SAH-00265
EKS-SUS-00249
EKS-TAG-00294
EKS-TAR-00366
EKS-TEN-00367
EKS-TUB-00024
EKS-TUT-00041
EKS-XET-00357
EKS-XIM-00357
Gene Ontology
GO:0009986; C:cell surface
GO:0005737; C:cytoplasm
GO:0005887; C:integral to plasma membrane
GO:0017002; F:activin-activated receptor activity
GO:0005524; F:ATP binding
GO:0046872; F:metal ion binding
GO:0004674; F:protein serine/threonine kinase activity
GO:0004712; F:protein serine/threonine/tyrosine kinase activity
GO:0004702; F:receptor signaling protein serine/threonine kinase activity
GO:0005024; F:transforming growth factor beta-activated receptor activity
GO:0032147; P:activation of protein kinase activity
GO:0009952; P:anterior/posterior pattern specification
GO:0060840; P:artery development
GO:0001974; P:blood vessel remodeling
GO:0030509; P:BMP signaling pathway
GO:0007368; P:determination of left/right symmetry
GO:0048617; P:embryonic foregut morphogenesis
GO:0001702; P:gastrulation with mouth forming second
GO:0007507; P:heart development
GO:0030073; P:insulin secretion
GO:0001822; P:kidney development
GO:0030324; P:lung development
GO:0001946; P:lymphangiogenesis
GO:0060836; P:lymphatic endothelial cell differentiation
GO:0007498; P:mesoderm development
GO:0042475; P:odontogenesis of dentin-containing tooth
GO:0035265; P:organ growth
GO:0060021; P:palate development
GO:0031016; P:pancreas development
GO:0032927; P:positive regulation of activin receptor signaling pathway
GO:0030501; P:positive regulation of bone mineralization
GO:0045669; P:positive regulation of osteoblast differentiation
GO:0009791; P:post-embryonic development
GO:0009749; P:response to glucose stimulus
GO:0061298; P:retina vasculature development in camera-type eye
GO:0023014; P:signal transduction by phosphorylation
GO:0048705; P:skeletal system morphogenesis
GO:0060841; P:venous blood vessel development
KEGG
hsa:93;
InterPros
IPR000333; Activin_II/TGFBeta-II_recpt.
IPR015768; Activin_II_recpt.
IPR000472; Activin_rcpt.
IPR011009; Kinase-like_dom.
IPR000719; Prot_kinase_cat_dom.
IPR008271; Ser/Thr_kinase_AS.
Pfam
PF01064; Activin_recp; 1.
PF00069; Pkinase; 1.
SMARTs
Prosites
PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
PS50011; PROTEIN_KINASE_DOM; 1.
PS00108; PROTEIN_KINASE_ST; 1.
Prints
PR00653; ACTIVIN2R.
Created Date20-Feb-2013